Beacon Therapeutics
Signal active
Organization
Contact Information
Overview
Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.
About
Industries
Health Care, Therapeutics
Founded
2023
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Beacon Therapeutics headquartered in Europe, operates in the Health Care, Therapeutics sector. The company focuses on Health Care and has secured $4.6B in funding across 16 round(s). With a team of 11-50 employees, Beacon Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Series B - Beacon Therapeutics, raised $170.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
6
Lead Investors
0
Total Funding Amount
$290.1M
Details
2
Beacon Therapeutics has raised a total of $290.1M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 120.1M | ||
| 2024 | Early Stage Venture | 170.0M |
Investors
Beacon Therapeutics is funded by 20 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Ekaterina Smirnyagina | - | FUNDING ROUND - Ekaterina Smirnyagina | 170.0M |
| Oxford Science Enterprises | - | FUNDING ROUND - Oxford Science Enterprises | 170.0M |
| Beacon Therapeutics | - | FUNDING ROUND - Beacon Therapeutics | 170.0M |
| University of Oxford | - | FUNDING ROUND - University of Oxford | 170.0M |
Recent Activity
There is no recent news or activity for this profile.